Inhibition of Chondrosarcoma Growth by mTOR Inhibitor in an In Vivo Syngeneic Rat Model

BACKGROUND: Chondrosarcomas are the second most frequent primary malignant type of bone tumor. No effective systemic treatment has been identified in advanced or adjuvant phases for chondrosarcoma. The aim of the present study was to determine the antitumor effects of doxorubicin and everolimus, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Jennifer, Decouvelaere, Anne Valérie, Pointecouteau, Thomas, Pissaloux, Daniel, Michot, Jean Philippe, Besse, Anthony, Blay, Jean Yves, Dutour, Aurélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384598/
https://www.ncbi.nlm.nih.gov/pubmed/22761648
http://dx.doi.org/10.1371/journal.pone.0032458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384598/
https://www.ncbi.nlm.nih.gov/pubmed/22761648
http://dx.doi.org/10.1371/journal.pone.0032458

Ejemplares similares